Vitality Biopharma to Present at SeeThruEquity 3rd Annual Innovations Investor Conference in Miami

ID: 1487268
recent pressrelease next pressrelease

(businesspress24) - LOS ANGELES, CA -- (Marketwired) -- 02/16/17 -- (OTCQB: VBIO) ("Vitality Biopharma," "Vitality," or the "Company") a corporation dedicated to the development of cannabinoid prodrug pharmaceuticals, and to unlocking the power of cannabinoids for the treatment of serious neurological and inflammatory disorders, is pleased to advise there will be a corporate presentation at the SeeThruEquity 3rd Annual Innovations Investor Conference to be held on Wednesday, February 22nd at the W Hotel, in South Beach, Miami.

Company CEO Robert Brooke will provide a 30-minute overview of Vitality Biopharma''s business during his presentation, and will be available to participate in one-on-one meetings with scheduled investors.

SeeThruEquity 3rd Annual Innovations Investor Conference
Wednesday, February 22, 2017
9:30 AM Eastern
, 2201 Collins Avenue, Miami Beach, FL, 33139

Investors and other interested parties will be able view a webcast of the presentation by visiting
for up to 120 days after the event. To review a printable copy of the presentation itself, please visit the investors section of the Vitality Biopharma website at .

(OTCQB: VBIO)
Vitality Biopharma is dedicated to unlocking the power of cannabinoids for the treatment of serious neurological and inflammatory disorders. For more information, visit: . Follow us on , and .

This news release contains "forward-looking statements" as that term is defined in Section 27(a) of the United States Securities Act of 1933, as amended and Section 21(e) of the Securities Exchange Act of 1934, as amended. Statements in this press release which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such factors include, among others, the inherent uncertainties associated with new projects and development stage companies. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-K for the most recent fiscal year, our quarterly reports on Form 10-Q and other periodic reports filed from time-to-time with the Securities and Exchange Commission.

1-530-231-7800



More information:
http://www.recycledplasticbuildingmaterials.co.uk https://www.amazon.com/Best-Scar-Cream-Stretch-Removal/dp/B00RSN5N8G http://www.melnorthey.com/commercial-outdoor-lights/ https://issuu.com/headphonesforkidsguide/docs/issuu_1_-_why_clip-on_headphones_ar h



Keywords (optional):

stvf, vitality-biopharma, cannabinoids, seethruequity, miami, investor, conference, neurological, ceo,



Company information / Profile:

PressRelease by

Requests:



PressContact / Agency:



published by: Marketwired
print pressrelease  send to a friend  

Date: 02/16/2017 - 07:55
Language: English
News-ID 1487268
Character count: 3037
Kontakt-Informationen:
Firma: Vitality Biopharma, Inc.
Ansprechpartner: Feedback to businesspress24.com about Pressrelease-id:
Stadt: LOS ANGELES, CA
Telefon:

Meldungsart:
Versandart:
Freigabedatum:
Comments:



Number of hits: 181

Linking-Tips:



Direct Link to this PressRelease:






We would appreciate a link in your News-, Press- or Partner-Site.

Comments on this PressRelease






All members: 9 438
Register today: 0
Register yesterday: 0
Members online: 0
Guests online: 74


Don't have an account yet? You can create one. As registered user you have some advantages like theme manager, comments configuration and post comments with your name.